English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort Journal article
Tang, Liang Jie, Sun, Dan Qin, Song, Sherlot Juan, Yip, Terry Cheuk Fung, Wong, Grace Lai Hung, Zhu, Pei Wu, Chen, Sui Dan, Karsdal, Morten, Leeming, Diana Julie, Jiang, Pei, Wang, Cong, Chen, Qiang, Byrne, Christopher D., Targher, Giovanni, Eslam, Mohammed, George, Jacob, Wong, Vincent Wai Sun, Zheng, Ming Hua. Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort[J]. Liver International, 2024, 44(5), 1129-1141.
Authors:  Tang, Liang Jie;  Sun, Dan Qin;  Song, Sherlot Juan;  Yip, Terry Cheuk Fung;  Wong, Grace Lai Hung; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:6.0/6.3 | Submit date：2024/05/16
Chronic Kidney Disease  Liver Fibrosis  Metabolic Dysfunction-associated Fatty Liver Disease  Metabolic Dysfunction-associated Steatotic Liver Disease  N-terminal Propeptide Of Type 3 Collagen  Risk Prediction  
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD Journal article
Liang‑Jie Tang, Gang Li, Mohammed Eslam, Pei‑Wu Zhu, Sui‑Dan Chen, Howard Ho‑Wai Leung, Ou‑Yang Huang, Grace Lai‑Hung Wong, Yu‑Jie Zhou, Morten Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Hai‑Yang Yuan, Christopher D. Byrne, Giovanni Targher, Jacob George, Vincent Wai‑Sun Wong, Ming‑Hua Zheng. N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD[J]. Hepatology International, 2022, 17, 190–201.
Authors:  Liang‑Jie Tang;  Gang Li;  Mohammed Eslam;  Pei‑Wu Zhu;  Sui‑Dan Chen; et al.
Favorite | TC[WOS]:10 TC[Scopus]:9  IF:5.9/6.6 | Submit date：2023/01/30
Metabolic Dysfunction-associated Fatty Liver Disease  Steatohepatitis  Sequential Algorithm  Fibrosis Staging